Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma
Mike J.P. de Jong(Radboud University Nijmegen), Peter D. Siersema(University Medical Center Utrecht), John J. Hermans(Erasmus MC), Erwin-Jan M. van Geenen(Radboud University Nijmegen), Tanya M. Bisseling(Radboud University Nijmegen), T. H. Perik(Radboud University Nijmegen), Foke van Delft(Maine Farmland Trust), Fons van der Sommen(Eindhoven University of Technology), Fer D W Radstake(Eindhoven University of Technology), Geke Litjens(Radboud University Nijmegen)
Cited by 0
Related Papers
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations
|Clinical Gastroenterology and Hepatology|2010|532
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493